Association of clinical and aetiologic subtype of acute ischaemic stroke with inflammation, oxidative stress and vascular function: A cross-sectional observational study

Medical Science Monitor

Volumn 17, Issue 9, 2011, Pages

  Beer, Christopher ^a,b,c,d   Blacker, David ^b,e   Hankey, Graeme J ^b,d   Puddey, Ian B ^b,d  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d ROYAL PERTH HOSPITAL   (Australia)

^e SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

Acute stroke; Endothelium; Inflammation; Oxidative stress

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRINOGEN; ISOPROSTANE DERIVATIVE; PROTEIN S100B; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CELL ACTIVATION; CELL DAMAGE; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OXIDATIVE STRESS; TRANSIENT ISCHEMIC ATTACK; VASCULAR DISEASE;

EID: 80054016170     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.881931     Document Type: Article

References (29)

1. Hoffmann M, Chichkova R, Ziyad M, Malek A: Too much lumping in ischemic stroke - a new classifcation. Med Sci Monit, 2004; 10(7): 285-87
2. Kocer A, Canbulat C, Gozke E, Ilhan A: C-reactive protein is an indicator for fatal outcomes in frst-time stroke patients. Med Sci Monit, 2005; 11(11): 540-44
3. Eikelboom JW, Hankey GJ, Baker RI et al: C-reactive protein in ischemic stroke and its etiologic subtypes. Journal of Stroke and Cerebrovascular Diseases, 2003; 12(2): 74-81
4. Guldiken B, Guldiken S, Turgut B et al: The roles of oxidized low-density lipoprotein and interleukin-6 levels in acute atherothrombotic and lacunar ischemic stroke. Angiology, 2008; 59(2): 224-29
5. Hoshi T, Kitagawa K, Yamagami H et al: Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infarction. Stroke, 2005; 36(4): 768-72
6. Markus HS, Hunt B, Palmer K et al: Markers of endothelial and he-mostatic activation and progression of cerebral white matter hyperin-tensities: longitudinal results of the Austrian Stroke Prevention Study. Stroke, 2005; 36(7): 1410-14
7. van Dijk EJ, Prins ND, Vermeer SE et al: C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation, 2005; 112(6): 900-5
8. Kelly PJ, Morrow JD, Ning M et al: Oxidative Stress and Matrix Metalloproteinase-9 in Acute Ischemic Stroke: The Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) Study. Stroke, 2008, 39(1): 100-4
9. Senes M, Kazan N, Coskun O et al: Oxidative and nitrosative stress in acute ischaemic stroke. Ann Clin Biochem, 2007; 44(Pt 1): 43-47
10. Ozkul A, Akyol A, Yenisey C et al: Oxidative stress in acute ischemic stroke. J Clin Neurosci, 2007; 14(11): 1062-66
11. Uno M, Kitazato KT, Nishi K et al: Raised plasma oxidised LDL in acute cerebral infarction. J Neurol Neurosurg Psychiatry, 2003; 74(3): 312-16
12. Bamford J, Sandercock P, Dennis M et al: Classifcation and natural history of clinically identifable subtypes of cerebral infarction. Lancet, 1991; 337(8756): 1521-26
13. Adams HP Jr, Bendixen BH, Kappelle LJ et al: Classifcation of subtype of acute ischemic stroke. Defnitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke, 1993; 24(1): 35-41
14. Brott T, Adams HP Jr, Olinger CP et al: Measurements of acute cerebral infarction: a clinical examination scale. Stroke, 1989; 20(7): 864-70
15. Bamford JM, Sandercock PA, Warlow CP, Slattery J: Interobserver agreement for the assessment of handicap in stroke patients. Stroke, 1989; 20(6): 828
16. Sulter G, Steen C, De Keyser J: Use of the Barthel index and modifed Rankin scale in acute stroke trials. Stroke, 1999; 30(8): 1538-41
17. Agrell B, Dehlin O: Mini mental state examination in geriatric stroke patients. Validity, differences between subgroups of patients, and relationships to somatic and mental variables. Aging (Milano), 2000; 12(6): 439-44
18. Herrmann M, Ehrenreich H: Brain derived proteins as markers of acute stroke: their relation to pathophysiology, outcome prediction and neu-roprotective drug monitoring. Restor Neurol Neurosci, 2003; 21(3-4): 177-90
19. Muir KW, Weir CJ, Alwan W et al: C-Reactive Protein and Outcome After Ischemic Stroke. Stroke, 1999; 30(5): 981-85
20. Cherian P, Hankey GJ, Eikelboom JW et al: Endothelial and platelet activation in acute ischemic stroke and its etiological subtypes. Stroke, 2003; 34(9): 2132-37
21. Sanchez-Moreno C, Dashe JF, Scott T et al: Decreased Levels of Plasma Vitamin C and Increased Concentrations of Infammatory and Oxidative Stress Markers After Stroke. Stroke, 2004; 35(1): 163-68
22. Rivera J, Ward N, Hodgson J et al: Measurement of 20-hydroxyeicosa-tetraenoic acid in human urine by gas chromatography-mass spectrom-etry. Clin Chem, 2004; 50(1): 224-26
23. Mori TA, Croft KD, Puddey IB, Beilin LJ: An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chroma-tography-mass spectrometry. Anal Biochem. 1999; 268(1): 117-25
24. Goodwin J, Bilous M, Winship S et al: Validation of the Oscar 2 oscillo-metric 24-h ambulatory blood pressure monitor according to the British Hypertension Society protocol. Blood Press Monit, 2007; 12(2): 113-17
25. Jones SC, Bilous M, Winship S et al: Validation of the OSCAR 2 oscil-lometric 24-hour ambulatory blood pressure monitor according to the International Protocol for the validation of blood pressure measuring devices. Blood Press Monit, 2004; 9(4): 219-23
26. Castillo J, Leira R, Garcia MM et al: Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome. Stroke, 2004; 35(2): 520-26
27. Guldiken B, Demir M, Guldiken S et al: Oxidative Stress and Total Antioxidant Capacity in Diabetic and Nondiabetic Acute Ischemic Stroke Patients. Clin Appl Thromb Hemost, 2008; 15(6): 695-700
28. Cao JJ, Thach C, Manolio TA et al: C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study. Circulation, 2003; 108(2): 166-70
29. Kofoed SC, Wittrup HH, Sillesen H, Nordestgaard BG: Fibrinogen predicts ischaemic stroke and advanced atherosclerosis but not echolucent, rupture-prone carotid plaques: the Copenhagen City Heart Study. Eur Heart J, 2003; 24(6): 567-76